Subscribe To
Merck inks oncology, neurology drug discovery pact with british biotech, curve therapeutics
Privately-held Curve Therapeutics has inked a contract with Merck & Co Inc (NYSE: MRK) to discover and validate modulators of up to five therapeut...
February 16, 2022, 2:01 pm
Merck inks oncology, neurology drug discovery pact with british biotech, curve therapeutics
Privately-held Curve Therapeutics has inked a contract with Merck & Co Inc (NYSE: MRK) to discover and validate modulators of up to five therapeut...
February 16, 2022, 2:01 pm
Merck inks oncology, neurology drug discovery pact with british biotech, curve therapeutics
Privately-held Curve Therapeutics has inked a contract with Merck & Co Inc (NYSE: MRK) to discover and validate modulators of up to five therapeut...
February 16, 2022, 2:01 pm
Transfix sees record results ahead of public listing
Digital freight platform Transfix announced fourth-quarter growth in key financial metrics Tuesday. Full-year 2021 provided the company with many mile...
February 15, 2022, 5:36 pm
Transfix sees record results ahead of public listing
Digital freight platform Transfix announced fourth-quarter growth in key financial metrics Tuesday. Full-year 2021 provided the company with many mile...
February 15, 2022, 5:36 pm
Transfix sees record results ahead of public listing
Digital freight platform Transfix announced fourth-quarter growth in key financial metrics Tuesday. Full-year 2021 provided the company with many mile...
February 15, 2022, 5:36 pm
Bullish technical events suggest gains for these 3 small caps
With key inflation data looming and earnings season heating up, things could remain volatile in small cap land. This could mean more gains ahead for s...
February 10, 2022, 4:03 am
Bullish technical events suggest gains for these 3 small caps
With key inflation data looming and earnings season heating up, things could remain volatile in small cap land. This could mean more gains ahead for s...
February 10, 2022, 4:03 am
Bullish technical events suggest gains for these 3 small caps
With key inflation data looming and earnings season heating up, things could remain volatile in small cap land. This could mean more gains ahead for s...
February 10, 2022, 4:03 am
Vox royalty says 2022 is gearing up to be a "record year" with key milestones within its royalty portfolio
Vox Royalty (TSX-V:VOX) Corp has provided investors a glimpse into its royalty portfolio with recent development and exploration updates from five par...
February 8, 2022, 10:33 am
Vox royalty says 2022 is gearing up to be a "record year" with key milestones within its royalty portfolio
Vox Royalty (TSX-V:VOX) Corp has provided investors a glimpse into its royalty portfolio with recent development and exploration updates from five par...
February 8, 2022, 10:33 am
Vox royalty says 2022 is gearing up to be a "record year" with key milestones within its royalty portfolio
Vox Royalty (TSX-V:VOX) Corp has provided investors a glimpse into its royalty portfolio with recent development and exploration updates from five par...
February 8, 2022, 10:33 am
Wisekey shares pop after sharing key business milestones for 2021
Cybersecurity and IoT company WISeKey International Holding Ltd (NASDAQ: WKEY) summarised its key business mile...
December 29, 2021, 12:38 pm
Wisekey shares pop after sharing key business milestones for 2021
Cybersecurity and IoT company WISeKey International Holding Ltd (NASDAQ: WKEY) summarised its key business mile...
December 29, 2021, 12:38 pm
Wisekey shares pop after sharing key business milestones for 2021
Cybersecurity and IoT company WISeKey International Holding Ltd (NASDAQ: WKEY) summarised its key business mile...
December 29, 2021, 12:38 pm
Genmab: ready for more growth in 2022
Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...
December 22, 2021, 11:38 pm
Genmab: ready for more growth in 2022
Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...
December 22, 2021, 11:38 pm
Genmab: ready for more growth in 2022
Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...
December 22, 2021, 11:38 pm
Adma biologics: turning a corner
On November 10th, ADMA reported a great quarter. Revenue grew to $20.68M, up 101.2% y/y, and the Company reached a number of mile...
November 20, 2021, 2:01 pm
Adma biologics: turning a corner
On November 10th, ADMA reported a great quarter. Revenue grew to $20.68M, up 101.2% y/y, and the Company reached a number of mile...
November 20, 2021, 2:01 pm